Free Trial
→ Recession Fears Mounting? 2 AI Stocks to Watch Now (From Darwin) (Ad)
NYSE:SENS

Senseonics 11/9/2023 Earnings Report

Senseonics logo
$0.51 +0.01 (+1.09%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$0.51 +0.00 (+0.22%)
As of 06/20/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings HistoryForecast

Senseonics EPS Results

Actual EPS
-$0.04
Consensus EPS
-$0.04
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Senseonics Revenue Results

Actual Revenue
$6.10 million
Expected Revenue
$5.44 million
Beat/Miss
Beat by +$660.00 thousand
YoY Revenue Growth
N/A

Senseonics Announcement Details

Quarter
Date
11/9/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Senseonics Earnings Headlines

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
June 4, 2025 | globenewswire.com
Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories
May 21, 2025 | quiverquant.com
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
June 21, 2025 | Brownstone Research (Ad)
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement
May 21, 2025 | globenewswire.com
Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity
May 21, 2025 | seekingalpha.com
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
May 15, 2025 | globenewswire.com
See More Senseonics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Senseonics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senseonics and other key companies, straight to your email.

About Senseonics

Senseonics (NYSE:SENS), a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

View Senseonics Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles